Most pancreatic cancers are treated with combinations of chemotherapy, surgery when resectable, and radiation in selected cases. Irreversible electroporation has been investigated as an adjunct in borderline or locally advanced tumours that cannot be fully resected upfront.
The intent in published protocols is often cytoreduction at the interface between tumour and vessels, or extension of local control after induction chemotherapy, not a substitute for systemic treatment. Complication profiles include pancreatic fistula risk and need for high-level surgical ICU support.
Imaging review by pancreatic surgeons, radiation and medical oncologists is essential. Trials and registry data differ by era and technique.
See IRE (NanoKnife) for the generic technology description.
You can ask for a second opinion on imaging, diagnosis and treatment options before you decide.
